Literature DB >> 10971728

Cathepsin D expression in early cutaneous malignant melanoma.

I Bartenjev1, Z Rudolf, B Stabuc, I Vrhovec, T Perkovic, A Kansky.   

Abstract

BACKGROUND: The aspartic proteinase cathepsin D is believed to be associated with proteolytic processes leading to the invasion and seeding of tumor cells. An association between cathepsin D tissue concentration and aggressiveness of tumors has been detected in different cancer types, as well as in metastatic melanoma.
METHODS: The concentration of cathepsin D was measured immunoradiometrically (ELSA-CATH-D kit, CIS Bio International) in the cytosols of 51 primary cutaneous melanomas (with Breslow index < 4 mm) to estimate the tissue concentrations of cathepsin D in early cutaneous melanoma.
RESULTS: A significantly elevated concentration of cathepsin D was measured in the tumor cytosols as compared to adjacent normal tissue (44.2 vs. 14.7 pmol/mg of total protein, P < 0.001).
CONCLUSIONS: Our results indicate that cathepsin D is expressed at high levels by melanoma cells. The extremely high expression of cathepsin D in two of our patients, with later progression of the disease over a 42-month follow-up period, suggests a possible correlation between the cathepsin D tissue concentration and the prognosis of primary cutaneous malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971728     DOI: 10.1046/j.1365-4362.2000.00025.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

Review 1.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

2.  A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.

Authors:  Mee-Jung Han; Huan Wang; Lynn A Beer; Hsin-Yao Tang; Meenhard Herlyn; David W Speicher
Journal:  Proteomics       Date:  2010-11-17       Impact factor: 3.984

Review 3.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Clinical utility of serum autoantibodies detected by protein microarray in melanoma.

Authors:  Michael S Sabel; Yashu Liu; Kent A Griffith; Jintang He; Xaiolei Xie; David M Lubman
Journal:  Int J Proteomics       Date:  2011-10-19

5.  Expression and Localization of Cathepsins B, D and G in Cancer Stem Cells in Liver Metastasis From Colon Adenocarcinoma.

Authors:  Shreeja Mehrotra; Susrutha K Wickremesekera; Helen D Brasch; Bede Van Schaijik; Reginald W Marsh; Swee T Tan; Tinte Itinteang
Journal:  Front Surg       Date:  2018-06-07

6.  Melanoma Mediated Disruption of Brain Endothelial Barrier Integrity Is Not Prevented by the Inhibition of Matrix Metalloproteinases and Proteases.

Authors:  Akshata Anchan; Graeme Finlay; Catherine E Angel; James J W Hucklesby; Scott E Graham
Journal:  Biosensors (Basel)       Date:  2022-08-19

7.  Human giant congenital melanocytic nevus exhibits potential proteomic alterations leading to melanotumorigenesis.

Authors:  Hyoung Kyu Kim; Yong Kyu Kim; In-Sung Song; Sung-Ryul Lee; Seung Hun Jeong; Min Hee Kim; Dae Yun Seo; Nari Kim; Byoung Doo Rhee; Kyoung Soo Ko; Kwan Chul Tark; Chul Gyoo Park; Je-Yoel Cho; Jin Han
Journal:  Proteome Sci       Date:  2012-08-20       Impact factor: 2.480

8.  Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays.

Authors:  Chandra Kirana; Hongjun Shi; Emma Laing; Kylie Hood; Rose Miller; Peter Bethwaite; John Keating; T William Jordan; Mark Hayes; Richard Stubbs
Journal:  Int J Proteomics       Date:  2012-08-07

9.  Activity of cathepsin D and α1-antitrypsin in blood of men with malignant melanoma.

Authors:  Rafał Kuźniewski
Journal:  Postepy Dermatol Alergol       Date:  2014-06-13       Impact factor: 1.837

10.  AGR2 is associated with gastric cancer progression and poor survival.

Authors:  Jun Zhang; Yongming Jin; Shaonan Xu; Jiayin Zheng; Q I Zhang; Yuanyu Wang; Jinping Chen; Yazeng Huang; Xujun He; Zhongsheng Zhao
Journal:  Oncol Lett       Date:  2016-01-29       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.